Lp(a) With CCTA Assessed Parameters and Clinical Outcomes
- Conditions
- Coronary Artery Disease
- Registration Number
- NCT05323227
- Lead Sponsor
- Shanghai Zhongshan Hospital
- Brief Summary
Lipoprotein(a) \[Lp(a)\] is a risk factor for cardiovascular events, although the underlying mechanism remains unclear. This study evaluated the relationship between Lp(a) and high-risk attributes (HRA) by coronary computed tomography angiography (CCTA) as well as their prognostic value.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 378
Inclusion Criteria
- Patients with Lp(a) meaured within 1 week of CCTA examination.
Exclusion Criteria
- unstable angina pectoris
- acute myocardial infarction
- New York Heart Association class III-IV heart failure
- with a history of bypass surgery
- active infection
- respiratory failure
- chronic kidney disease (estimated glomerular filtration rate [eGFR] <60 ml/min/1.73 m2)
- liver dysfunction (liver enzyme >3 upper reference limit [URL] or bilirubin >2 URL)
- malignancy
- systemic connective tissue disease
- poor CCTA imaging quality not suitable for analysis
- other situations not suitable for the study
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Association of Lp(a) level with CCTA measured Parameters at the index procedure Association of Lp(a) level with CCTA measured high-risk plaque characteristics
Major adverse cardiac events at 24 months from index procedure a composite of cardiac death, any myocardial infarction, and stroke
- Secondary Outcome Measures
Name Time Method Stroke at 24 months from index procedure stroke
Cardiac death at 24 months from index procedure Cardiac death
Myocardial infarction at 24 months from index procedure Myocardial infarction
Trial Locations
- Locations (1)
Shanghai Zhongshan Hospital
🇨🇳Shanghai, China
Shanghai Zhongshan Hospital🇨🇳Shanghai, ChinaNeng Dai, MDContact+8613701997266niceday1987@hotmail.comJunbo Ge, MDPrincipal Investigator